Novel monoclonal and polyclonal antibodies
QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout its history, their goals have remained unchanged: provide the best antibody products and services on the market and support their clients with the expertise and assistance they should expect from a full-spectrum antibody company.
QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. These antibodies are developed using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. QED is a full-service corporation, and offers additional immunochemistry services such as purification and conjugation so to provide clients with an antibody product that will work specifically within their system. QED Bioscience also develops monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.
- Recombinant Proteins
- SERION Immunologics Native and Recombinant Antigens
- Infectious Disease Test Kits
- Cell Culture Products